Bharat Biotech says COVAXIN will have at least 60% effectiveness
Biotechnology company Bharat Biotech said on Sunday that Covaxin, its coronavirus vaccine candidate, will be at least 60% effective, reported News18. The statement was based on the trial data of the vaccine candidate.
The company said that while it aimed to achieve at least 60% efficacy, it could actually be more. “Chances of the vaccine being less than 50% effective are remote, as suggested by our trial results so far,” it said.